文献速递神经肿瘤

混合荧光素引导垂体腺瘤切除术的初步研究

Hybrid fluorescein-guided surgery for pituitary adenoma resection: a pilot study.
PubMed 文献 · J Neurosurg · 2019-04-05

本研究为初步研究,纳入连续的功能性和非功能性垂体腺瘤患者,采用内镜下鼻内入路,暴露蝶窦后静脉推注8 mg/kg荧光素钠,在YELLOW 560滤镜下交替使用内镜和显微镜引导切除。共纳入15例患者,无荧光素钠相关过敏反应,尿液、皮肤和黏膜黄染均在24小时内消退;光谱分析显示肿瘤、腺体和瘢痕组织间荧光差异有统计学意义(p=0.01)。作者认为该技术安全可行。

要点

  • 静脉推注8 mg/kg荧光素钠在YELLOW 560滤镜下可辅助区分肿瘤、腺体和瘢痕组织。
  • 15例患者中无荧光素钠相关过敏反应,黄染在24小时内消退。
  • 该技术可能有助于激素分泌性和复发性肿瘤的手术效果及缩短学习曲线。

核心结论

  • 荧光素钠引导垂体腺瘤切除术安全可行,可能改善手术结果,尤其对激素分泌性和复发性肿瘤,并缩短学习曲线。

研究设计与样本

  • 初步研究,纳入所有连续的功能性和非功能性垂体腺瘤患者,共15例(男7例,女8例)。

主要发现

  • 7例(46%)为非功能性,6例(40%)为GH分泌性,1例(7%)为泌乳素分泌性,1例(7%)为ACTH分泌性。
  • 无荧光素钠相关过敏反应,所有患者出现尿液、皮肤和黏膜黄染,最长24小时内消退。
  • 光谱分析显示肿瘤、腺体和瘢痕组织间荧光差异有统计学意义(p=0.01)。

关键数值与推荐

  • 静脉推注荧光素钠剂量为8 mg/kg。
  • 使用YELLOW 560滤镜观察荧光。
  • 荧光差异统计学显著性为p=0.01。

临床怎么用

  • 内镜下鼻内入路暴露蝶窦后静脉推注8 mg/kg荧光素钠,在YELLOW 560滤镜下交替使用内镜和显微镜引导切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors conducted a pilot study on hybrid fluorescein-guided surgery for pituitary adenoma resection and herein describe the feasibility and safety of this technique. METHODS: In this pilot study, the authors included all consecutive patients presenting with pituitary adenomas, functioning and nonfunctioning. They performed a hybrid fluorescein-guided surgical technique for tumor resection. An endonasal endoscopic approach was used; after exposure of the rostrum of the sphenoid sinus, they administered a bolus of 8 mg/kg of fluorescein sodium (FNa) intravenously, and during resection, they alternated between endoscopic and microscopic techniques to guide the resection under a YELLOW 560 filter. RESULTS: The study included 15 patients, 7 men (47%) and 8 women (53%). Of the pituitary adenomas, 7 (46%) were nonfunctioning, 6 (40%) were GH secreting, 1 (7%) was prolactin secreting, and 1 (7%) was ACTH secreting. There were no FNa-related complications (anaphylactic reactions); yellowish staining of urine, skin, and mucosa was seen in all patients and resolved in a maximum time of 24 hours. After color spectrophotometric analysis, the authors identified a statistical difference in fluorescence among tumor, gland, and scar tissue (p = 0.01). CONCLUSIONS: This is the first study of its kind to describe the feasibility and safety of using FNa to guide the resection of pituitary adenomas. The authors found this technique to be safe and feasible. It may be used to obtain better surgical results, especially for hormone-producing and recurring tumors, as well as for reducing the learning curve in pituitary adenoma surgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Romano-Feinholz S, Alcocer-Barradas V, Benítez-Gasca A, et al. Hybrid fluorescein-guided surgery for pituitary adenoma resection: a pilot study. J Neurosurg. 2019. PMID: 30952130. doi:10.3171/2019.1.JNS181512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。